|
Text Size: A+| A-| A   |   Text Only Site   |   Accessibility
Health Resources Commission

Evidence Based Reports
Updated 03.31.08
Updated 03.31.08
 
Alzheimer or ALZ
Angiotensin Converting Enzyme Inhibitors or ACEI
Angiotensin II Receptor Antagonists or AIIRA
Antiemetics or NAE
Antihistamines or AH
Antiplatelet or AP
Autism or ASD                                                                       
Beta 2 Agonists or B2
Beta Blocker or BB
Calcium Channel Blockers or CCB
Hormone Replacement Therapy - HRT
Inhaled Corticosteroid or ICS
Long-acting Analgesics for Non-cancer Pain or OPOID
Neuropathic Pain
Non-steroidal Anti-inflammatory Drugs or NSAIDS
Obesity
Oral Hypoglycemics or OH
Over Active Bladder or OAB
Peginterferons for Hepatitis C
Proton Pump Inhibitor or PPI
Skeletal Muscle Relaxers or SMR
STATIN
Targeted Immune Modulators or TIM
Thiazolidinediones or TZD
TRIPTAN
Urinary Incontinence or UI

 
 
Page updated: March 31, 2008

Text Only | State Directories | Agencies A to Z | Site Map | About Oregon.gov | Oregon.gov|
File Formats | Oregon Administrative Rules | Oregon Revised Statutes | Privacy Policy | Web Site Feedback|

Get Adobe Acrobat ReaderAdobe Reader is required to view PDF files. Click the "Get Adobe Reader" image to get a free download of the reader from Adobe.